BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 4024140)

  • 1. Ability of a mixture of antimyotoxin a serum and polyvalent (Crotalidae) antivenin to neutralize myonecrosis, hemorrhage and lethality induced by prairie rattlesnake (Crotalus viridis viridis) venom.
    Ownby CL; Colberg TR; Odell GV
    Toxicon; 1985; 23(2):317-24. PubMed ID: 4024140
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo ability of antimyotoxin a serum plus polyvalent (Crotalidae) antivenom to neutralize prairie rattlesnake (Crotalus viridis viridis) venom.
    Ownby CL; Colberg TR; Odell GV
    Toxicon; 1986; 24(2):197-200. PubMed ID: 3705096
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ability of polyvalent (Crotalidae) antivenin to neutralize myonecrosis, hemorrhage and lethality induced by timber rattlesnake (Crotalus horridus horridus) venom.
    Smith MS; Ownby CL
    Toxicon; 1985; 23(3):409-24. PubMed ID: 3927522
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo test of the ability of antiserum to myotoxin a from prairie rattlesnake (Crotalus viridis viridis) venom to neutralize local myonecrosis induced by myotoxin a and homologous crude venom.
    Ownby CL; Colberg TR; Claypool PL; Odell GV
    Toxicon; 1984; 22(1):99-105. PubMed ID: 6719480
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new method for quantitating hemorrhage induced by rattlesnake venoms: ability of polyvalent antivenom to neutralize hemorrhagic activity.
    Ownby CL; Colberg TR; Odell GV
    Toxicon; 1984; 22(2):227-33. PubMed ID: 6729841
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of antibodies to myotoxin a and prairie rattlesnake (Crotalus viridis viridis) venom in three antisera using enzyme-linked immunosorbent assay and immunodiffusion.
    Ownby CL; Odell GV; Theakston RD
    Toxicon; 1983; 21(6):849-55. PubMed ID: 6419394
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ability of polyvalent (Crotalidae) antivenom to neutralize local myonecrosis induced by Crotalus atrox venom.
    Ownby CL; Colberg TR
    Toxicon; 1986; 24(2):201-3. PubMed ID: 3705097
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preclinical assessment of the ability of polyvalent (Crotalinae) and anticoral (Elapidae) antivenoms produced in Costa Rica to neutralize the venoms of North American snakes.
    Arce V; Rojas E; Ownby CL; Rojas G; Gutiérrez JM
    Toxicon; 2003 Jun; 41(7):851-60. PubMed ID: 12782085
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of the biological and immunological properties of fractions of prairie rattlesnake (Crotalus viridis viridis) venom.
    Ownby CL; Colberg TR
    Toxicon; 1987; 25(12):1329-42. PubMed ID: 3125631
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ability of a polyvalent antivenom to neutralize the venom of Lachesis muta melanocephala, a new Costa Rican subspecies of the bushmaster.
    Gutiérrez JM; Rojas G; Cerdas L
    Toxicon; 1987; 25(7):713-20. PubMed ID: 3672541
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neutralization of edema, hemorrhage and myonecrosis induced by North American crotalid venoms in simulated first-aid treatments.
    Evans J; Ownby CL
    Toxicon; 1999 Apr; 37(4):633-50. PubMed ID: 10082163
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ability of antiserum to myotoxin alpha from prairie rattlesnake (Crotalus viridis viridis) venom to neutralize local myotoxicity and lethal effects of myotoxin alpha and homologous crude venom.
    Ownby CL; Odell GV; Woods WM; Colberg TR
    Toxicon; 1983; 21(1):35-45. PubMed ID: 6845385
    [No Abstract]   [Full Text] [Related]  

  • 13. Comparison of a new ovine antigen binding fragment (Fab) antivenin for United States Crotalidae with the commercial antivenin for protection against venom-induced lethality in mice.
    Consroe P; Egen NB; Russell FE; Gerrish K; Smith DC; Sidki A; Landon JT
    Am J Trop Med Hyg; 1995 Nov; 53(5):507-10. PubMed ID: 7485708
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Neutralization of toxic and enzyme activities of 4 venoms from snakes of Guatemala and Honduras by the polyvalent antivenin produced in Costa Rica].
    Rojas G; Gutiérrez JM; Gené JA; Gómez M; Cerdas L
    Rev Biol Trop; 1987 Jun; 35(1):59-67. PubMed ID: 3444924
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Observations on white and yellow venoms from an individual southern Pacific rattlesnake (Crotalus viridis helleri).
    Johnson EK; Kardong KV; Ownby CL
    Toxicon; 1987; 25(11):1169-80. PubMed ID: 3124297
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of antivenin on intramuscular pressure elevations induced by rattlesnake venom.
    Garfin SR; Castilonia RR; Mubarak SJ; Hargens AR; Akeson WH; Russell FE
    Toxicon; 1985; 23(4):677-80. PubMed ID: 4060178
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rattlesnake venom-induced thrombocytopenia response to Antivenin (Crotalidae) Polyvalent: a case series.
    Bush SP; Wu VH; Corbett SW
    Acad Emerg Med; 2000 Feb; 7(2):181-5. PubMed ID: 10691078
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neutralization of proteolytic and hemorrhagic activities of Costa Rican snake venoms by a polyvalent antivenom.
    Gutiérrez JM; Gené JA; Rojas G; Cerdas L
    Toxicon; 1985; 23(6):887-93. PubMed ID: 3913055
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ability of six Latin American antivenoms to neutralize the venom of mapaná equis (Bothrops atrox) from Antioquia and Chocó (Colombia).
    Otero R; Nuñez V; Osorio RG; Gutiérrez JM; Giraldo CA; Posada LE
    Toxicon; 1995 Jun; 33(6):809-15. PubMed ID: 7676472
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Classification of myonecrosis induced by snake venoms: venoms from the prairie rattlesnake (Crotalus viridis viridis), western diamondback rattlesnake (Crotalus atrox) and the Indian cobra (Naja naja naja).
    Ownby CL; Colberg TR
    Toxicon; 1988; 26(5):459-74. PubMed ID: 3188052
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.